88.15
Abivax Adr stock is traded at $88.15, with a volume of 885.32K.
It is down -1.01% in the last 24 hours and down -25.70% over the past month.
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
See More
Previous Close:
$89.05
Open:
$90.21
24h Volume:
885.32K
Relative Volume:
0.67
Market Cap:
$7.69B
Revenue:
Net Income/Loss:
$-386.19M
P/E Ratio:
-16.78
EPS:
-5.2547
Net Cash Flow:
$-206.27M
1W Performance:
-3.90%
1M Performance:
-25.70%
6M Performance:
-30.12%
1Y Performance:
-5.99%
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, MRNA, REGN, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ABVX
Abivax Adr
|
88.15 | 7.69B | 0 | -386.19M | -206.27M | -5.2547 |
|
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-26 | Upgrade | Jefferies | Hold → Buy |
| Jun-02-26 | Downgrade | Jefferies | Buy → Hold |
| Jun-02-26 | Upgrade | Wedbush | Underperform → Neutral |
| Mar-16-26 | Initiated | Jefferies | Buy |
| Feb-24-26 | Initiated | Wedbush | Outperform |
| Nov-24-25 | Initiated | Truist | Buy |
| Nov-06-25 | Initiated | Wolfe Research | Outperform |
| Oct-13-25 | Initiated | Barclays | Overweight |
| Jul-23-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-25 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jul-29-24 | Initiated | Laidlaw | Buy |
| May-20-24 | Initiated | BTIG Research | Buy |
| Apr-29-24 | Initiated | Guggenheim | Buy |
| Apr-29-24 | Initiated | Piper Sandler | Overweight |
| Nov-14-23 | Initiated | Leerink Partners | Outperform |
| Nov-14-23 | Initiated | Morgan Stanley | Equal-Weight |
View All
Abivax Adr Stock (ABVX) Latest News
ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the GapDownward Estimate Revision - careplusvn.com
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressLow Growth Earnings - dars.gov.et
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressEBITDA Estimate Trend - dars.gov.et
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressRevenue Breakdown Analysis - dars.gov.et
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why - Yahoo Finance
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsBreadth Thrust - siam.in
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsWeekly Profile - careplusvn.com
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsLate Stage Breakouts - dars.gov.et
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight - GlobeNewswire Inc.
Readystate Asset Management LP Raises Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Velan Capital Investment Management LP Sells 11,370 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Stock Holdings Increased by Seven Fleet Capital Management LP - MarketBeat
Abivax (ABVX) Quarterly Scorecard: Profit Per Share Falls Below Its Benchmark in the Reported Period - dars.gov.et
Abivax (ABVX) EPS and Revenue: EPS Misses Its Estimate in the Current Update; After Earnings: The Stock Loses 2.75% in Latest TradingEPS Surprise History - careplusvn.com
Abivax (ABVX) EPS and Revenue: EPS Misses Its Estimate in the Current Update; After Earnings: The Stock Loses 2.75% in Latest TradingEarnings Sentiment Score - dars.gov.et
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction: Shares Move Higher 1.36% in the Latest SessionEarnings Quality Score - dars.gov.et
Abivax SA Sponsored ADR $ABVX Shares Sold by Royal Bank of Canada - MarketBeat
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction: Shares Move Higher 1.36% in the Latest SessionProduct Revenue Analysis - careplusvn.com
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction - dars.gov.et
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordIPO Entry Watch - careplusvn.com
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordLast Point Support - dars.gov.et
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordMoney Flow Index - dars.gov.et
Abivax (ABVX): TCG Crossover and Chen Yu report 7.0% ADS stake - Stock Titan
Abivax S.A. (ABVX) investors report 6.0% beneficial stake via Invus entities - Stock Titan
ABIVAX (NASDAQ:ABVX) Flashes Strong Technical Rating and Breakout Setup - ChartMill
Bank of America Corp DE Purchases 213,440 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Militia Capital Management LLC Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Perceptive Advisors LLC Cuts Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Seven Fleet Capital Management LP Has $4.79 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Recommendation of "Moderate Buy" by Analysts - marketbeat.com
Avidity Partners Management LP Takes $1.11 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Vivo Capital LLC - MarketBeat
ABVX Q4 2025 Earnings: Wider-than-Expected Net Loss, Shares Still Climb 4.62%Earnings Quality Score - www.dars.gov.et
Stempoint Capital LP Has $34.94 Million Stock Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR Revenue Breakdown – FWB:2X10 - TradingView
Ally Bridge Group NY LLC Lowers Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Eversept Partners LP Has $104.05 Million Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Octagon Capital Advisors LP - MarketBeat
Orbimed Advisors LLC Has $51.86 Million Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Hsbc Holdings PLC Has $1.71 Million Stock Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Caxton Associates LLP Acquires Shares of 24,750 Abivax SA Sponsored ADR $ABVX - MarketBeat
Affinity Asset Advisors LLC Has $45.10 Million Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR Revenue Breakdown – SWB:2X10 - TradingView
Abivax SA Sponsored ADR $ABVX Position Increased by PSquared Asset Management AG - MarketBeat
Atika Capital Management LLC Sells 26,200 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
ABIVAX Société Anonyme (ABVX) stock price, news, quote and history - Yahoo Finance UK
ABIVAX Société Anonyme (ABVX) Stock Price, News, Quote & History - Yahoo! Finance Canada
ABIVAX Société Anonyme (ABVX) stock price, news, quote and history - Yahoo Finance Singapore
17,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Militia Capital Management LLC - MarketBeat
ETFs Investing in Abivax SA Sponsored ADR Stocks - TradingView
Abivax Adr Stock (ABVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Abivax Adr Stock (ABVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sofinnova Crossover I SLP | Affiliate |
Oct 28 '25 |
Proposed Sale |
92.75 |
1,200,000 |
111,300,000 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):